Abstract:Background: FGF21 increases glucose uptake in adipocytes by enhancing the expression of glucose transporter-1 (GLUT1). Results: FGF21 induces the phosphorylation of the transcription factors serum response factor (SRF) and Ets-like protein-1 (Elk-1), which in turn bind to a highly conserved cis-element within the GLUT1 gene promoter for transcriptional activation. Such a stimulatory effect of FGF21 is impaired in adipose tissue of diet-induced obese mice. Conclusion: SRF and Elk-1 act synergistically to mediate FGF21-induced GLUT1 gene expression in adipocytes. Significance: The findings provide new molecular insights into the metabolic actions of FGF21 in its major target tissue. Fibroblast growth factor 21 (FGF21) is a liver-secreted endocrine factor with multiple beneficial effects on obesity-related disorders. It enhances glucose uptake by inducing the expression of glucose transporter-1 (GLUT1) in adipocytes. Here we investigated the signaling pathways that mediate FGF21-induced GLUT1 expression and glucose uptake in vitro and in animals. Quantitative real-time PCR and a luciferase reporter assay showed that FGF21 induced GLUT1 expression through transcriptional activation. The truncation of the GLUT1 promoter from −3145 to −3105 bp, which contains two highly conserved serum response element (SRE) and E-Twenty Six (ETS) binding motif, dramatically decreased FGF21-induced promoter activity of the GLUT1 gene. A chromatin immunoprecipitation assay demonstrated that the transcription factors serum response factor (SRF) and Ets-like protein-1 (Elk-1) were recruited to the GLUT1 promoter upon FGF21 stimulation. The siRNA-mediated knockdown of either SRF or Elk-1 resulted in a marked attenuation in FGF21-induced GLUT1 expression and glucose uptake in adipocytes. In C57 lean mice, a single intravenous injection of FGF21 induced phosphorylation of Elk-1 at Ser383 and SRF at Ser103 and also led to the recruitment of Elk-1 and SRF to the GLUT1 promoter in epididymal fats. By contrast, such effects of in vivo FGF21 administration were blunted in high fat diet-induced obese mice. In conclusion, FGF21 induces GLUT1 expression and glucose uptake through sequential activation of ERK1/2 and SRF/Elk-1, which in turn triggers the transcriptional activation of GLUT1 in adipocytes. The impairment in this signaling pathway may contribute to FGF21 resistance in obese mice.

Serum Fibroblast Growth Factor 1 is Associated with the Decreased Risk of Obesity in Human

High Circulating Fibroblast Growth Factor-21 Levels as a Prognostic Marker in Fatty Pancreas Patients

High circulating fibroblast growth factor-21 levels as a screening marker in fatty pancreas patients

Factors Associated with Fasting Plasma Ghrelin Levels in Children and Adolescents

Fibroblast Growth Factor 21 Increases Insulin Sensitivity Through Specific Expansion of Subcutaneous Fat

FGF1 ameliorates obesity-associated hepatic steatosis by reversing IGFBP2 hypermethylation

Serum Fetuin B Level Increased in Subjects of Nonalcoholic Fatty Liver Disease: a Case-Control Study.

Obesity is associated with increased levels of circulating hepatocyte growth factor

Serum FGF21 levels are increased in newly diagnosed type 2 diabetes with nonalcoholic fatty liver disease and associated with hsCRP levels independently.

Serum fibroblast growth factor 21 in overweight and obese Thai children and adolescents: its relation to glucose metabolism and its change after glucose loading

Serum Liver-Type Fatty Acid Binding Protein Level and Related Factors in Obese Young Adults

The role of fibroblast growth factor 21 in metabolic processes in patients with gastrointestinal diseases

Fibroblast Growth Factor 21 Induces Glucose Transporter-1 Expression through Activation of the Serum Response Factor/Ets-Like Protein-1 in Adipocytes*

Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives

Serum betatrophin level increased in subjects with nonalcoholic fatty liver disease

Circulating Fibroblast Growth Factor 21 Levels Are Closely Associated with Hepatic Fat Content: A Cross-Sectional Study

Fibroblast growth factor-1 (FGF-1) promotes adipogenesis by downregulation of carboxypeptidase A4 (CPA4) – a negative regulator of adipogenesis implicated in the modulation of local and systemic insulin sensitivity

The relationship between serum FGF-23 concentration and insulin resistance, prediabetes and dyslipidemia in obese children and adolescents

Association of serum fibroblast growth factor 21 with kidney function in a population-based Chinese cohort

Targeted Deletion of Fibroblast Growth Factor 23 Rescues Metabolic Dysregulation of Diet-induced Obesity in Female Mice

Serum Fibroblast Growth Factor 19 Levels Are Decreased in Chinese Subjects With Impaired Fasting Glucose and Inversely Associated With Fasting Plasma Glucose Levels